擅长领域：胸腹部肿瘤尤其是食管癌、肝癌的临床诊断、放射治疗及综合治疗。 

执业经历： 一、基本情况 　　专业特长：胸腹部肿瘤尤其是食管癌、肝癌的临床诊断、放射治疗及综合治疗。 　　主要研究方向：1、食管癌的放射治疗与综合治疗;2、放射治疗新技术在肝癌的临床应用研究;3、鼻咽癌放疗后放射诱发肿瘤的临床研究。 　　专家门诊时间：周二下午 　　二、学习及工作经历 　　1999.09-2004.06 郑州大学医学院临床医学系本科 　　2004.09-2007.06 中山大学肿瘤防治中心肿瘤学硕士 　　2010.09-2013.06 中山大学肿瘤防治中心肿瘤学博士 　　2007.08-2010.12 中山大学肿瘤防治中心放疗科住院医师 　　2011.01-2015.12 中山大学肿瘤防治中心放疗科主治医师 　　2016.01-至今中山大学肿瘤防治中心放疗科副主任医师 　　三、主持科研项目 　　1. 国家自然科学基金青年项目(81201748)：调强放射治疗诱导鼻咽癌放疗后第二恶性肿瘤发生的物理效应和调控研究。23万元，第1负责人; 　　2. 广东省科技计划项目(2012B061700083)：不同放疗技术对鼻咽癌放疗后诱发恶性肿瘤的物理效应研究。5万元，第1负责人; 　　3. 广东省食管癌研究所科技计划青年项目(Q201401)：局部晚期食管鳞癌多西他赛+顺铂诱导化疗联合同期放化疗的前瞻性随机对照Ⅱ期临床研究。5万元，第1负责人。 　　四、已发表论文(第一或通讯作者) 　　1) Liu SL, Xi M (corresponding author), Yang H, Yang YD, Wu YJ, Zhao L, Zhang P, Luo LL, Liu MZ. Is there a correlation between clinical complete response and pathological complete response after neoadjuvant chemoradiotherapy for esophageal squamous cell cancer Ann SurgOncol. 2016; 23(1): 273-281. 　　2) Liu SL, Yang H, Zhang P, Zhang L, Zhao L, Luo LL, Fu JH, Liu MZ, Xi M (corresponding author). Neoadjuvant chemoradiotherapy with cisplatin plus vinorelbine versus cisplatin plus fluorouracil for esophageal squamous cell carcinoma: a matched case–control study. RadiotherOncol. 2015; 116(2): 262-268. 　　3) Zhang P, Xi M (co-first author), Zhao L, Qiu B, Liu H, Hu YH, Liu MZ. Clinical efficacy and failure pattern in patients with cervical esophageal cancer treated with definitive chemoradiotherapy. RadiotherOncol. 2015; 116(2): 257-261. 　　4) Xi M, Liu SL, Zhao L, Shen JX, Zhang L, Zhang P, Liu MZ. Prognostic factors and survival in patients with radiation-related second malignant neoplasms following radiotherapy for nasopharyngeal carcinoma. PLoS One. 2013; 8(12): e84586. 　　5) Xi M, Zhang L, Zhao L, Li QQ, Guo SP, Feng ZZ, Deng XW, Huang XY, Liu MZ. Effectiveness of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombosis. PLoS One. 2013; 8(5): e63864. 　　6) Zhang P, Xi M (co-first author), Zhao L, Li QQ, He LR, Liu SL, Shen JX, Liu MZ. Efficacy and prognostic analysis of chemoradiotherapy in patients with thoracic esophageal squamous carcinoma with cervical lymph nodal metastases alone. RadiatOncol. 2014; 9(1): 256. 　　7) Zhang P, Xi M (co-first author), Li QQ, He LR, Liu SL, Zhao L, Shen JX, Liu MZ. The modified glasgow prognostic score is an independent prognostic factor in patients with inoperable thoracic esophageal squamous cell carcinoma undergoing chemoradiotherapy. J Cancer. 2014; 5(8): 689-695. 　　8) Zhang P, Xi M (co-first author), Zhao L, Shen JX, Li QQ, He LR, Liu SL, Liu MZ. Is there a benefit in receiving concurrent chemoradiotherapy for elderly patients with inoperable thoracic esophageal squamous cell carcinoma? PLoS One. 2014; 9(8): e105270. 　　9) Zhang P, Xi M (co-first author), Zhao L, Li QQ, He L, Liu S, Shen J, Liu MZ. Unilateral cervical nodal metastasis is an independent prognostic factor for esophageal squamous cell carcinoma undergoing chemoradiotherapy: A retrospective study. PLoS One. 2014; 9(6): e101332. 　　10) Xi M, Zhang L, Li QQ, Zhao L, Zhang R, Liu MZ. Assessing the role of volumetric-modulated arc therapy in hepatocellular carcinoma. J ApplClin Med Phys. 2013; 14(3): 4162. 　　11) Zhang L, Xi M (co-first author), Deng XW, Li QQ, Huang XY, Liu MZ. Four-dimensional CT-based evaluation of volumetric modulated arc therapy for abdominal lymph node metastasis from hepatocellular carcinoma. J Radiat Res. 2012; 53(5): 769-776. 　　12) Xi M, Zhang L, Liu MZ, Deng XW, Huang XY, Liu H. Dosimetric analysis of respiratory gated radiotherapy for hepatocellular carcinoma. Med Dosim. 2011; 36(2): 213-218. 　　13) Xi M, Zhang L, Liu MZ, Li QQ. Radiation-induced malignancy following definitive radiotherapy for nasopharyngeal carcinoma. Ann Oncol. 2012; 23S(9): 1048p. (Abstract) 　　14) Xi M, Liu MZ, Wang HX, Cai L, Zhang L, Xie CF, Li QQ. Radiation-induced sarcoma in patients with nasopharyngeal carcinoma: a single-institution study. Cancer. 2010; 116(23): 5479-5486. 　　15) Xi M, Liu MZ, Zhang L, Li QQ, Huang XY, Liu H, Hu YH. How many sets of 4DCT images are sufficient to determine internal target volume for liver radiotherapy? RadiotherOncol. 2009; 92(2): 255-259. 　　16) Xi M, Liu MZ, Deng XW, Zhang L, Huang XY, Liu H, Li QQ, Hu YH, Cai L, Cui NJ. Defining internal target volume (ITV) for hepatocellular carcinoma using four-dimensional CT. RadiotherOncol. 2007; 84(3): 272-278. 详细介绍